Protease inhibitors are crucial in the treatment of HIV and other viruses as they specifically target viral proteases essential for the synthesis of viral proteins. These inhibitors block the proteolytic cleavage required for the maturation of HIV proteins, which are initially expressed as a single long chain. By preventing this cleavage, protease inhibitors disrupt the virus's replication and release. While proteases are widely known for their role in digestion, they also perform vital functions such as blood clotting and apoptosis. The HIV protease is distinct enough from human proteases, allowing for targeted drug action without affecting the body's other protease functions.